References
- Perez RS , ZollingerPE , DijkstraPUet al. CRPS I task force . Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurol.10, 20 (2010).
- Stanton-Hicks M , JanigW , HassenbuschS , HaddoxJD , BoasR , WilsonP. Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain63(1), 127–133 (1995).
- Veldman PH , ReynenHM , ArntzIE , GorisRJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet342(8878), 1012–1016 (1993).
- Geertzen JH , DijkstraPU , GroothoffJW , ten DuisHJ , EismaWH. Reflex sympathetic dystrophy of the upper extremity – a 5.5-year follow-up. Part II. Social life events, general health and changes in occupation. Acta Orthop. Scand. Suppl.279, 19–23 (1998).
- Geertzen JH , DijkstraPU , GroothoffJW , ten DuisHJ , EismaWH. Reflex sympathetic dystrophy of the upper extremity – a 5.5-year follow-up. Part I. Impairments and perceived disability. Acta Orthop. Scand. Suppl.279, 12–18 (1998).
- Harden RN , BruehlS , PerezRSet al. Validation of proposed diagnostic criteria (the ‘Budapest criteria’) for complex regional pain syndrome. Pain150(2), 268–274 (2010).
- Tran DQ , DuongS , BertiniP , FinlaysonRJ. Treatment of complex regional pain syndrome: a review of the evidence. Can. J. Anaesth.57(2), 149–166 (2010).
- Mackey S , FeinbergS. Pharmacologic therapies for complex regional pain syndrome. Curr. Pain Headache Rep.11(1), 38–43 (2007).
- Harke H , GretenkortP , LadleifHU , RahmanS , HarkeO. The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study. Anesth. Analg.92(2), 488–495 (2001).
- Gronseth GS , WoodroffeLM , GetchiusTS. Amendments to 2011 American Academy of Neurology clinical practice guideline process manual. American Academy of Neurology35–40 (2015).
- Serpell MG , Neuropathicpain study group. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain99(3), 557–566 (2002).
- van de Vusse AC , Stomp-vanden Berg SG , KesselsAH , WeberWE. Randomised controlled trial of gabapentin in complex regional pain syndrome type 1 [ISRCTN84121379]. BMC Neurol.4, 13 (2004).
- Tan AK , DumanI , TaskaynatanMA , HazneciB , KalyonTA. The effect of gabapentin in earlier stage of reflex sympathetic dystrophy. Clin. Rheumatol.26(4), 561–565 (2007).
- Mellick GA , MellickLB. Reflex sympathetic dystrophy treated with gabapentin. Arch. Phys. Med. Rehabil.78(1), 98–105 (1997).
- Akkus S , YorgancigilH , YenerM. A case of recurrent and migratory complex regional pain syndrome type I: prevention by gabapentin. Rheumatol. Int.26(9), 852–854 (2006).
- Wheeler DS , VauxKK , TamDA. Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy. Pediatr. Neurol.22(3), 220–221 (2000).
- Saltik S , SozenHG , BasgulS , KaratoprakEY , IcagasiogluA. Pregabalin treatment of a patient with complex regional pain syndrome. Pediatr. Neurol.54, 88–90 (2016).
- Takahashi Y , TominagaT , OkawaK , TanakaK. Recovery from acute pediatric complex regional pain syndrome type I after ankle sprain by early pharmacological and physical therapies in primary care: a case report. J. Pain Res.11, 2859–2866 (2018).
- Wossner S , WeberK , SteinbeckAC , OberhauserM , FeuereckerM. Pregabalin as adjunct in a multimodal pain therapy after traumatic foot amputation: a case report of a 4-year-old girl. Scand. J. Pain17, 146–149 (2017).
- Pedemonte Stalla V , MediciOlaso C , KanopaAlmada V , GonzalezRabelino G. Complex regional pain syndrome type i. An analysis of 7 cases in children. Neurologia30(6), 347–351 (2015).
- Lalwani K , ShohamA , KohJL , McGrawT. Use of oxcarbazepine to treat a pediatric patient with resistant complex regional pain syndrome. J. Pain6(10), 704–706 (2005).
- Brown S , JohnstonB , AmariaKet al. A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children. Scand. J. Pain13, 156–163 (2016).
- McQuay H , CarrollD , JadadAR , WiffenP , MooreA. Anticonvulsant drugs for management of pain: a systematic review. BMJ311(7012), 1047–1052 (1995).
- Jensen SA , WalkerTL , HutterJW , NicollBK. Comparison of the cleaning efficacy of passive sonic activation and passive ultrasonic activation after hand instrumentation in molar root canals. J. Endod.25(11), 735–738 (1995).
- Backonja M , BeydounA , EdwardsKRet al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA280(21), 1831–1836 (1998).
- Rowbotham M , HardenN , StaceyB , BernsteinP , Magnus-MillerL. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA280(21), 1837–1842 (1998).
- Dickenson AH , MatthewsEA , SuzukiR. Neurobiology of neuropathic pain: mode of action of anticonvulsants. Eur. J. Pain6(Suppl. A), 51–60 (2002).
- Jensen TS . Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur. J. Pain6(Suppl. A), 61–68 (2002).
- Ichikawa K , KoyamaN , KiguchiS , KojimaM , YokotaT. Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibers. Eur. J. Pharmacol.420(2–3), 119–122 (2001).
- Stefani A , SpadoniF , GiacominiP , LavaroniF , BernardiG. The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons. Epilepsy Res.43(3), 239–248 (2001).
- Obata H . Analgesic mechanisms of antidepressants for neuropathic pain. Int. J. Mol. Sci.18(11), 2483 (2017).
- Wertli M , BachmannLM , WeinerSS , BrunnerF. Prognostic factors in complex regional pain syndrome 1: a systematic review. J. Rehabil. Med.45(3), 225–231 (2013).
- Bean DJ , JohnsonMH , KyddRR. The outcome of complex regional pain syndrome type 1: a systematic review. J. Pain15(7), 677–690 (2014).
- Kiguchi S , ImamuraT , IchikawaK , KojimaM. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy. Clin. Exp. Pharmacol. Physiol.31(1–2), 57–64 (2004).